Sanofi-Aventis And Xuanwu Hospital Capital Medical University To Set Up Regeneration Lab
This article was originally published in PharmAsia News
Executive Summary
Sanofi-Aventis will cooperate with Xuanwu Hospital Capital Medical University to set up a regeneration laboratory to focus on research of the central nervous system, metabolic disorders and geriatric diseases. Since 2007, the company has established strategic partnerships with China's leading academic institutions. These include Tianjin Institute of Hematology and Blood Diseases Hospital, which comes under the Chinese Academy of Medical Sciences; and Shanghai Institute for Biological Sciences. Sanofi-Aventis disclosed that it is likely to launch a new oncology drug by the end of the year. The company's China operation currently prioritizes R&D and it will continue to build close partnerships with academic institutions. (Click here for more - Chinese Language)